1. Anon., 2004. Graduate of the TDR “malperox” programme reaches the clinics. TDR News No. 73, 6–7.
2. Anon., 2005a. Applying genomics to drug discovery research. TDR News No. 74, 2.
3. Anon., 2005b. TDR partnered and sponsored research has led to two recent regulatory approvals. TDR News No. 74, 3.
4. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells;Bonjean;Biochemistry,1998
5. Natural products as sources of antiprotozoal drugs;del Rayo Camacho Corona;Current Opinion in Anti-infective Investigational Drugs,2000